Page last updated: 2024-10-29

ifosfamide and Cancer of Colon

ifosfamide has been researched along with Cancer of Colon in 15 studies

Research Excerpts

ExcerptRelevanceReference
"Three murine tumor lines, B16 melanoma, C38 colon cancer and M2661 breast cancer, were used to evaluate the therapeutic efficacy of the drug combination ACNU and ifosfamide."3.68Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer. ( Nooter, K; Silbermann, MH; Stoter, G; vd Vecht, B; Verweij, J, 1990)
"Paclitaxel was given after the first dose of ifosfamide on Day 1."2.69A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. ( Berkowitz, R; Bunnell, CA; Buswell, L; Muto, M; Sheets, E; Shulman, LN; Thompson, L, 1998)
" The seven agents combined with CI-973 were mitomycin C, cyclophosphamide, doxorubicin, vinblastine, etoposide, ifosfamide, and methotrexate."1.29Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. ( Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ, 1994)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19902 (13.33)18.7374
1990's8 (53.33)18.2507
2000's3 (20.00)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Behera, G1
Purkait, S1
Patra, S1
Sasmal, PK1
Majumdar, SKD1
Das, DK1
Naik, S1
Singh, PK1
Scheppach, W1
Reissmann, N1
Sprinz, T1
Schippers, E1
Schoettker, B1
Mueller, JG1
Arafa, HM1
Struck, RF1
Dykes, DJ1
Corbett, TH1
Suling, WJ1
Trader, MW1
Elliott, WL1
Roberts, BJ1
Howard, CT1
Leopold, WR1
Bunnell, CA1
Thompson, L1
Buswell, L1
Berkowitz, R1
Muto, M1
Sheets, E1
Shulman, LN1
Latz, D2
Schulze, T1
Manegold, C1
Schraube, P1
Flentje, M1
Weber, KJ2
Kusnierczyk, H1
Pajtasz-Piasecka, E1
Radzikowski, C1
Tilignac, T1
Temparis, S1
Combaret, L1
Taillandier, D1
Pouch, MN1
Cervek, M1
Cardenas, DM1
Le Bricon, T1
Debiton, E1
Samuels, SE1
Madelmont, JC1
Attaix, D1
Kaijser, GP1
Beijnen, JH1
Bult, A1
Wiese, G1
de Kraker, J1
Keizer, HJ1
Underberg, WJ1
Vierhout, ME1
Chadha-Ajwani, S1
Wijnen, JA1
Splinter, TA1
Zondervan, PE1
Ras, JH1
Drogendijk, AC1
Chauffert, B1
Dimanche-Boitrel, MT1
Genne, P1
Petit, JM1
Onier, N1
Jeannin, JF1
Silbermann, MH1
vd Vecht, B1
Stoter, G1
Nooter, K1
Verweij, J1
Kemeny, N1
Reichman, B1
Dougherty, J1
Lipperman, R1
Cheng, E1

Reviews

1 review available for ifosfamide and Cancer of Colon

ArticleYear
Extra-nodal Cytokeratin-Positive Interstitial Reticulum Cell Sarcoma Presenting as a Colonic Polyp: Report of a Rare Case with Review of Literature.
    Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colon; Col

2020

Trials

2 trials available for ifosfamide and Cancer of Colon

ArticleYear
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
    Cancer, 1998, Feb-01, Volume: 82, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Fe

1998
Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms;

1987

Other Studies

12 other studies available for ifosfamide and Cancer of Colon

ArticleYear
PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.
    World journal of gastroenterology, 2013, Mar-14, Volume: 19, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, A

2013
Possible contribution of beta-glucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells.
    European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3

    Topics: Animals; Antineoplastic Agents; beta-Glucosidase; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor;

2009
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide;

1983
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Cancer research, 1994, Aug-15, Volume: 54, Issue:16

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosph

1994
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1998, Volume: 46, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality T

1998
Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model.
    Medical oncology (Northwood, London, England), 1999, Volume: 16, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Colonic Neoplasms; Combined Modality The

1999
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
    Cancer research, 2002, May-15, Volume: 62, Issue:10

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cachexia; Cisplatin; Colonic Neoplasms; Cysteine End

2002
Transient DNA double-strand breakage in 4-hydroperoxyifosfamide-treated mammalian cells in vitro does not interact with the rejoining of radiation-induced double-strand breaks.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:5

    Topics: Animals; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; Dose

2002
Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine.
    Journal of chromatography, 1992, Dec-02, Volume: 583, Issue:2

    Topics: Chromatography, Gas; Colonic Neoplasms; Cyclophosphamide; Humans; Ifosfamide; Male; Middle Aged; Rep

1992
Extra-uterine endometrial stromal sarcoma with DNA flow cytometric analysis.
    European journal of obstetrics, gynecology, and reproductive biology, 1992, Jan-31, Volume: 43, Issue:2

    Topics: Adult; Colonic Neoplasms; DNA; Doxorubicin; Endometriosis; Female; Flow Cytometry; Follow-Up Studies

1992
[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
    Gastroenterologie clinique et biologique, 1992, Volume: 16, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Disease Models, Anim

1992
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Synergism; Ifosfami

1990